Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) ; volume:50 ; number:9 ; day:29 ; month:5 ; year:2023 ; pages:2830-2845 ; date:7.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 9 (29.5.2023), 2830-2845, 7.2023
- Creator
-
Kratochwil, Clemens
Fendler, Wolfgang P.
Eiber, Matthias
Hofman, Michael
Emmett, Louise
Calais, Jeremie
Osborne, Joseph R.
Iravani, Amir
Koo, Phillip
Lindenberg, Liza
Baum, Richard P.
Bozkurt, Murat Fani
Delgado Bolton, Roberto C.
Ezziddin, Samer
Forrer, Flavio
Hicks, Rodney
Hope, Thomas A.
Kabasakal, Levent
Konijnenberg, Mark
Kopka, Klaus
Lassmann, Michael
Mottaghy, Felix
Oyen, Wim J. G.
Rahbar, Kambiz
Schoder, Heiko
Virgolini, Irene
Bodei, Lisa
Fanti, Stefano
Haberkorn, Uwe
Hermann, Ken
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06255-8
- URN
-
urn:nbn:de:101:1-2023093011362335266906
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kratochwil, Clemens
- Fendler, Wolfgang P.
- Eiber, Matthias
- Hofman, Michael
- Emmett, Louise
- Calais, Jeremie
- Osborne, Joseph R.
- Iravani, Amir
- Koo, Phillip
- Lindenberg, Liza
- Baum, Richard P.
- Bozkurt, Murat Fani
- Delgado Bolton, Roberto C.
- Ezziddin, Samer
- Forrer, Flavio
- Hicks, Rodney
- Hope, Thomas A.
- Kabasakal, Levent
- Konijnenberg, Mark
- Kopka, Klaus
- Lassmann, Michael
- Mottaghy, Felix
- Oyen, Wim J. G.
- Rahbar, Kambiz
- Schoder, Heiko
- Virgolini, Irene
- Bodei, Lisa
- Fanti, Stefano
- Haberkorn, Uwe
- Hermann, Ken
- SpringerLink (Online service)
Other Objects (12)
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Long-term nephrotoxicity of 177Lu-PSMA radioligand therapy
177Lu-rhPSMA-10.1 induces tumor response in a patient with mCRPC after PSMA-directed radioligand therapy with 177Lu-PSMA-I AND T
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
Urinary excretion kinetics of [177Lu]Lu-PSMA-617
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Long-term nephrotoxicity of 177Lu-PSMA radioligand therapy
177Lu-rhPSMA-10.1 induces tumor response in a patient with mCRPC after PSMA-directed radioligand therapy with 177Lu-PSMA-I AND T
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
Urinary excretion kinetics of [177Lu]Lu-PSMA-617
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Long-term nephrotoxicity of 177Lu-PSMA radioligand therapy
177Lu-rhPSMA-10.1 induces tumor response in a patient with mCRPC after PSMA-directed radioligand therapy with 177Lu-PSMA-I AND T
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
Urinary excretion kinetics of [177Lu]Lu-PSMA-617